In a call hosted recently, Nasus Pharma (NYSE:NSRX) presented strong positive topline results from its Phase 2 clinical study ...

Based on real-world data, 92.3% of patients achieved rapid symptom resolution after receiving a single dose of epinephrine nasal spray for systemic reactions. Intranasal epinephrine was found to be ...

An initial dose of 0.3 mg intramuscular (IM) epinephrine was tied to a greater escalation of care than a dose of 0.5 mg in patients with anaphylaxis, a retrospective single-center study found. The ...

Please provide your email address to receive an email when new articles are posted on . The researchers identified 390 reactions requiring epinephrine during 1,637 cases of home administration of oral ...

Please provide your email address to receive an email when new articles are posted on . The costs of epinephrine autoinjectors have decreased since generic options arrived in 2016, but these costs ...

Epinephrine now available in a nasal spray formulation (neffy) is being hailed as a way to diminish barriers to use, which is critical in emergency situations such as an anaphylactic reaction. The ...

Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...